The Indian government is considering a one-year extension for small pharmaceutical manufacturers to comply with revised Good Manufacturing Practices (GMPs). This potential delay, ahead of the January 1, 2026 deadline, aims to support thousands of small drug makers struggling with the new quality standards, which are aligned with World Health Organization norms.